Ocuphire Pharma (IRD) P/E (2011 - 2026)
Ocuphire Pharma (IRD) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM Ocuphire Pharma (IRD) P/E is -1.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Ocuphire Pharma (IRD)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.97 | -20.56% |
| 2025 | -2.48 | +313.01% |
| 2024 | -0.60 | -127.13% |
| 2023 | 2.21 | -171.52% |
| 2022 | -3.09 | +279.20% |
| 2021 | -0.82 | -60.24% |
| 2020 | -2.05 | -73.42% |
| 2019 | -7.72 | -65.18% |
| 2018 | -22.17 | -0.33% |
| 2017 | -22.25 | -14.84% |
| 2016 | -26.12 | -43.52% |
| 2015 | -46.26 | -30.78% |
| 2014 | -66.83 | -4.01% |
| 2013 | -69.62 | +46.52% |
| 2012 | -47.52 | +63.60% |
| 2011 | -29.05 | N/A |
Comparison Ocuphire Pharma (IRD) P/E with competitors
Ocuphire Pharma (IRD) P/E is -1.97.